Thus Bcl-xl plays an important role in inhibiting TRAIL-induced apoptosis in this setting, while eEF2K coordinates TRAIL-modulated Bcl-xL expression in glioma cells [56]. This evidence concerns the gene BCL2L1 and central nervous system cancer.